Aldeyra Therapeutics
ALDX
$3.93
Share price
-0.25%
Change (1 day)
-58.76%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.11 B
According to Aldeyra Therapeutics
's latest financial reports the company has $0.11 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Aldeyra Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -20.67% |
| 2022-12-31 | $0.15 B | -26.6% |
| 2021-12-31 | $0.20 B | 245.72% |
| 2020-12-31 | $59.5 M | 23.76% |
| 2019-12-31 | $48.08 M | -44.49% |
| 2018-12-31 | $86.61 M | 118.73% |
| 2017-12-31 | $39.6 M | 82.92% |
| 2016-12-31 | $21.64 M | -12.98% |
| 2015-12-31 | $24.87 M | 295.9% |
| 2014-12-31 | $6.28 M | -430.04% |
| 2013-12-31 | $-1.91 M | -92.43% |
| 2012-12-31 | $-25.16 M | 977.5% |
| 2011-12-31 | $-2.34 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $25.97 B | 21,581.29% | 🇺🇸 USA |